Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis
Qian Wang, … , Zhi Yao, Lei Shi
Qian Wang, … , Zhi Yao, Lei Shi
Published May 16, 2016
Citation Information: J Clin Invest. 2016;126(6):2205-2220. https://doi.org/10.1172/JCI85747.
View: Text | PDF
Research Article Oncology

Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis

  • Text
  • PDF
Abstract

The histone demethylase PHF8 has been implicated in multiple pathological disorders, including X-linked mental retardation and tumorigenesis. However, it is not clear how the abundance and function of PHF8 are regulated. Here, we report that PHF8 physically associates with the deubiquitinase USP7. Specifically, we demonstrated that USP7 promotes deubiquitination and stabilization of PHF8, leading to the upregulation of a group of genes, including cyclin A2, that are critical for cell growth and proliferation. The USP7-encoding gene was also transcriptionally regulated by PHF8, via positive feedback. USP7 was overexpressed in breast carcinomas, and the level of expression positively correlated with expression of PHF8 and cyclin A2 and with the histological grade of breast cancer. We showed that USP7 promotes breast carcinogenesis by stabilizing PHF8 and upregulating cyclin A2 and that the interaction between USP7 and PHF8 is augmented during DNA damage. Moreover, USP7-promoted PHF8 stabilization conferred cellular resistance to genotoxic insults and was required for the recruitment of BLM and KU70, which are both essential for DNA double-strand break repair. Our study mechanistically links USP7 to epigenetic regulation and DNA repair. Moreover, these data support the pursuit of USP7 and PHF8 as potential targets for breast cancer intervention, especially in combination with chemo- or radiotherapies.

Authors

Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi

×

Figure 1

The deubiquitinase USP7 is physically associated with the histone demethylase PHF8.

Options: View larger image (or click on image) Download as PowerPoint
The deubiquitinase USP7 is physically associated with the histone demeth...
(A) Cellular extracts from MCF-7 cells with Dox-inducible expression of stably integrated FLAG-PHF8 were immunopurified with anti-FLAG affinity beads and eluted with FLAG peptides. The eluates were resolved on SDS-PAGE and silver-stained followed by mass spectrometry analysis. Representative peptide fragments of USP7 and peptide coverage of the indicated proteins are shown. Detailed results are provided as Supplemental Table 1. (B) Cell lysates from MCF-7 cells with Dox-inducible expression of stably integrated FLAG-PHF8 (top panel) or FLAG-USP7 (bottom panel) were immunoprecipitated (IP) and then immunoblotted with antibodies against the indicated proteins. (C) Whole cell lysates from MCF-7 cells (top panel) and HeLa cells (bottom panel) were immunoprecipitated and then immunoblotted with antibodies against the indicated proteins. (D) Cellular extracts from MCF-7 cells were fractionated on Superose 6 size exclusion columns. Chromatographic elution profiles (top panel) and Western blotting analysis (bottom panel) of the chromatographic fractions with antibodies against the indicated proteins are shown. The elution positions of calibration proteins with known molecular masses are indicated, and an equal volume from each fraction was analyzed. (E) Experiments analogous to D were performed with PHF8-containing protein complex purified from FLAG-PHF8–expressing MCF-7 cells. (F) MCF-7 cells and U2OS cells were fixed and immunostained with anti-USP7 and anti-PHF8. Scale bar: 10 μm.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts